Trial Profile
Single Asending Dose.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs JNJ 38431055 (Primary)
- Indications Diabetes mellitus
- Focus Adverse reactions
- 07 Jul 2009 Actual patient number (37) added as reported by ClinicalTrials.gov.
- 01 Jul 2009 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
- 01 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.